A new method for analyzing proteins using fewer samples
Accessible and Robust High-Throughput Western Blotting for Small Sample Sizes
['FUNDING_OTHER'] · BLOTTING INNOVATIONS, LLC · NIH-10545990
This study is testing a new, faster way to analyze proteins that could help labs work more efficiently and accurately, which might lead to quicker and better diagnoses for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BLOTTING INNOVATIONS, LLC (nih funded) |
| Locations | 1 site (CENTRAL, UNITED STATES) |
| Trial ID | NIH-10545990 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a high-throughput technique called mesowestern for analyzing proteins through western blotting. The mesowestern method allows for the analysis of over 300 samples simultaneously, significantly increasing efficiency while requiring much smaller sample sizes than traditional methods. By utilizing affordable and user-friendly technology, this approach aims to make protein analysis more accessible to various laboratories. Patients may benefit indirectly as this technique could lead to faster and more accurate diagnostics in biomedical research.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that require protein analysis for diagnosis or treatment monitoring.
Not a fit: Patients who do not require protein analysis or whose conditions are unrelated to protein biomarkers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the speed and accuracy of protein analysis, leading to improved diagnostic capabilities for various medical conditions.
How similar studies have performed: Previous research has shown success with high-throughput protein analysis methods, indicating a promising potential for this novel approach.
Where this research is happening
CENTRAL, UNITED STATES
- BLOTTING INNOVATIONS, LLC — CENTRAL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BIRTWISTLE, MARC R. — BLOTTING INNOVATIONS, LLC
- Study coordinator: BIRTWISTLE, MARC R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.